Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus: Clinical Trials

1 trial for Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus: new trials by email Literature Review of Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus trials Research Report on Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia
Cloxacillin, Cefazolin - Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
Not applicableCompletedAssistance Publique - Hôpitaux de Paris3152018-09-052025-11-24

Narrower conditions

Bacteremia (1)  ·  Staphylococcal Infections (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Cefazolin (1)  ·  Cloxacillin (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)

Top investigators

Xavier Lescure, MD, PhD (1)

Results publications

PMID 30173161, PMID 41115439